Green-tea extract
Also known as EGCG, green tea, camellia sinensis, green tea extract.
Concentrated green tea extract supplies catechins, mainly EGCG, in amounts far above those obtained by drinking tea.
Last reviewed September 20, 2026 · Jump to references
Educational information only. This page does not provide medical advice or determine whether a supplement is appropriate for you. Review supplements with a qualified healthcare professional, especially if you take medication, are pregnant, have surgery scheduled, or have a chronic medical condition.
Important cautions
Liver injury with concentrated extractshigh concern
Acute hepatitis, occasionally severe, has been reported with high-EGCG supplements, especially taken fasted or in weight-loss blends. Stop and seek urgent care for jaundice, dark urine, persistent nausea or abdominal pain.
Caffeine contentmoderate concern
Caffeinated products can cause palpitations, insomnia, anxiety and raised blood pressure, and add to other stimulants.
Avoid concentrated extracts in pregnancy and breastfeedingmoderate concern
Safety data are inadequate and caffeine intake also matters in pregnancy.
Reduces iron absorptionlow concern
Catechins bind non-haem iron; separate from iron supplements and iron-rich meals.
Discuss with a clinician if any of these apply
- Pregnancy or breastfeeding
- Liver disease
Evidence by use
Each use is rated on its own. There is no single overall effectiveness score.
Weight loss and weight maintenance
Limited or mixedEffects in trials are small and often not clinically meaningful.
Blood lipids and blood pressure
Limited or mixedSmall average changes reported in meta-analyses of green tea and extracts.
Cancer prevention
Insufficient evidenceObservational associations are inconsistent and trials do not establish benefit.
Exercise performance and fat oxidation
Limited or mixedSmall, inconsistent human findings.
Interactions to review
Iron supplements
supplement · moderate severity · moderate evidence
Catechins reduce non-haem iron absorption; separate intake.
Nadolol and some other medicines
medication · moderate severity · moderate evidence
Reduced drug exposure has been reported with green tea.
Bortezomib
medication · high severity · limited evidence
EGCG has been reported to reduce activity of this cancer medicine.
Other stimulants and caffeine sources
supplement · moderate severity · moderate evidence
Additive cardiovascular and sleep effects.
Liver disease or hepatotoxic medicines
condition · high severity · moderate evidence
Increases concern given reported hepatotoxicity.
Complete Research Guide
Open each section for the available evidence. Gaps are stated rather than inferred.
Overview
Green tea extract concentrates catechins, especially EGCG, into a capsule. People buy it mainly for weight loss and metabolism, where measured effects are small. The important distinction is dose form: brewed tea and concentrated extract are not the same exposure, and the extract carries a documented liver-injury signal.
Technical detail
Primary category: Antioxidant & Cellular Support; secondary: Metabolic & Cardiovascular. Alternate names: Camellia sinensis extract, EGCG, epigallocatechin gallate, GTE.
Section last reviewed Sep 20, 2026
Structure & Properties
Products differ in total catechins, EGCG content, caffeine content and whether they are decaffeinated. Ethanol-extracted, high-EGCG products taken on an empty stomach appear to carry the greatest liver concern.
Technical detail
Catechins oxidise readily; EGCG stability depends on pH and temperature. Labels may state extract weight rather than EGCG content, which is the value relevant to safety assessments. Store cool, dry and sealed.
Section last reviewed Sep 20, 2026
How It Works
Catechins have antioxidant activity and modestly affect fat oxidation and thermogenesis, with caffeine contributing when present.
Technical detail
Proposed mechanisms include catechol-O-methyltransferase inhibition prolonging noradrenaline signalling, effects on lipid absorption, and antioxidant and gene-regulatory effects. Human mechanistic translation is weak relative to the strength of marketing claims.
Section last reviewed Sep 20, 2026
Human Research
Meta-analyses of weight-loss trials show average reductions of about one to two kilograms at most, often not sustained or clinically important. Lipid and blood-pressure effects are small. Cancer-prevention claims are not supported by trial evidence.
Technical detail
Evidence assessed separately by outcome; heterogeneity across catechin dose, caffeine content and population is high. Adverse-event reporting in trials is inconsistent, so liver signals come largely from case reports and pharmacovigilance.
Section last reviewed Sep 20, 2026
Laboratory Research
Cell and animal work describes antioxidant activity, effects on adipocyte metabolism, and, at high concentrations, hepatocyte toxicity.
Evidence gap: Non-human evidence. Notably, the same laboratory literature supports both the marketed hypothesis and the toxicity concern; neither is established as a human clinical outcome.
Section last reviewed Sep 20, 2026
Processing & Interactions
Catechins reduce iron absorption and can interact with some medicines. Caffeine-containing products add stimulant effects. Taking extracts without food increases absorption and appears to increase liver risk.
Technical detail
Reduced non-haem iron absorption; reported reductions in nadolol exposure; possible effects on statins and other OATP substrates; EGCG has been reported to interfere with bortezomib activity. Caffeine content contributes to interactions with stimulants and with some psychiatric medicines. Green tea contains vitamin K in small amounts, relevant only at very high intake with warfarin.
Section last reviewed Sep 20, 2026
Safety & Precautions
The principal concern is liver injury: cases of acute hepatitis, some severe, have been reported with concentrated extracts, particularly high-EGCG products taken on an empty stomach and in weight-loss blends. Stop immediately and seek medical care for yellowing of the skin or eyes, dark urine, persistent nausea, abdominal pain or unusual fatigue. Caffeine-containing products can cause palpitations, insomnia and raised blood pressure. Avoid concentrated extracts in pregnancy and breastfeeding, and in existing liver disease. Drinking green tea as a beverage is a different and generally lower-risk exposure.
Section last reviewed Sep 20, 2026
Administration & Studied Formulations
Capsules and tablets, often within multi-ingredient weight-loss blends, are the common forms. Trials used defined catechin or EGCG amounts, which retail blends rarely disclose clearly.
Technical detail
Safety assessments have set a daily EGCG level above which hepatotoxicity risk increases for supplements; the linked sources give the current figures. Study amounts are not personal recommendations, and multi-ingredient blends make attribution of both benefit and harm difficult.
Section last reviewed Sep 20, 2026
Applications & Related Therapies
For weight management, evidence-supported approaches include dietary pattern change, physical activity, behavioural support, and where clinically indicated, prescribed therapy under supervision. Green tea extract is not a substitute for any of these, and the beverage is a reasonable food-first alternative to the concentrate.
Section last reviewed Sep 20, 2026
Cases, Considerations & Ethics
Educational example: an adult takes a high-EGCG fat-burner on an empty stomach, develops fatigue and jaundice after several weeks, and liver tests are markedly abnormal with no other cause. Decision factors are EGCG dose, fasted intake, multi-ingredient blends and other liver-affecting drugs or alcohol. Questions to ask: how much EGCG is in this, is it safe with my medicines, and what symptoms should make me stop? Ethically, selling a small average weight effect alongside a serious rare liver risk without clear warning is a recognised concern.
Section last reviewed Sep 20, 2026
References
- National Center for Complementary and Integrative HealthGreen teaAccessed September 20, 2026
- LiverTox (NIDDK / NLM)Green Tea — Clinical and Research Information on Drug-Induced Liver InjuryAccessed September 20, 2026
